These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7554356)

  • 41. Functional characterization of the RYR1 mutation p.Arg4737Trp associated with susceptibility to malignant hyperthermia.
    Johannsen S; Treves S; Müller CR; Mögele S; Schneiderbanger D; Roewer N; Schuster F
    Neuromuscul Disord; 2016 Jan; 26(1):21-5. PubMed ID: 26631338
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A substitution of cysteine for arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermia.
    Gillard EF; Otsu K; Fujii J; Khanna VK; de Leon S; Derdemezi J; Britt BA; Duff CL; Worton RG; MacLennan DH
    Genomics; 1991 Nov; 11(3):751-5. PubMed ID: 1774074
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Screening of the entire ryanodine receptor type 1 coding region for sequence variants associated with malignant hyperthermia susceptibility in the north american population.
    Sambuughin N; Holley H; Muldoon S; Brandom BW; de Bantel AM; Tobin JR; Nelson TE; Goldfarb LG
    Anesthesiology; 2005 Mar; 102(3):515-21. PubMed ID: 15731587
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Screening for mutations in the RYR1 gene in families with malignant hyperthermia.
    Muniz VP; Silva HC; Tsanaclis AM; Vainzof M
    J Mol Neurosci; 2003; 21(1):35-42. PubMed ID: 14500992
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A complex satellite DNA polymorphism flanking the human ryanodine receptor gene (RYR1).
    Wolz W; Wendelmuth U; Rouquier S; Giorgi D; Müller CR
    Cytogenet Cell Genet; 1996; 72(2-3):215-6. PubMed ID: 8978780
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacogenetics and pathophysiology of CACNA1S mutations in malignant hyperthermia.
    Beam TA; Loudermilk EF; Kisor DF
    Physiol Genomics; 2017 Feb; 49(2):81-87. PubMed ID: 28011884
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Malignant hyperthermia as a complication of anesthesia: predisposition is hereditary].
    Snoeck MM; Gielen MJ; Sengers RC; Padberg GW; Iles DE; Booij LH
    Ned Tijdschr Geneeskd; 1997 Mar; 141(13):616-9. PubMed ID: 9190536
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduced threshold for store overload-induced Ca
    Chen W; Koop A; Liu Y; Guo W; Wei J; Wang R; MacLennan DH; Dirksen RT; Chen SRW
    Biochem J; 2017 Aug; 474(16):2749-2761. PubMed ID: 28687594
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection of a novel ryanodine receptor subtype 1 mutation (R328W) in a malignant hyperthermia family by sequencing of a leukocyte transcript.
    Loke JC; Kraev N; Sharma P; Du G; Patel L; Kraev A; MacLennan DH
    Anesthesiology; 2003 Aug; 99(2):297-302. PubMed ID: 12883402
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Malignant hyperthermia in Japan: mutation screening of the entire ryanodine receptor type 1 gene coding region by direct sequencing.
    Ibarra M CA; Wu S; Murayama K; Minami N; Ichihara Y; Kikuchi H; Noguchi S; Hayashi YK; Ochiai R; Nishino I
    Anesthesiology; 2006 Jun; 104(6):1146-54. PubMed ID: 16732084
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The structural organization of the human skeletal muscle ryanodine receptor (RYR1) gene.
    Phillips MS; Fujii J; Khanna VK; DeLeon S; Yokobata K; de Jong PJ; MacLennan DH
    Genomics; 1996 May; 34(1):24-41. PubMed ID: 8661021
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection of a novel mutation at amino acid position 614 in the ryanodine receptor in malignant hyperthermia.
    Quane KA; Ording H; Keating KE; Manning BM; Heine R; Bendixen D; Berg K; Krivosic-Horber R; Lehmann-Horn F; Fagerlund T; McCarthy TV
    Br J Anaesth; 1997 Sep; 79(3):332-7. PubMed ID: 9389851
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sequence capture and massively parallel sequencing to detect mutations associated with malignant hyperthermia.
    Schiemann AH; Dürholt EM; Pollock N; Stowell KM
    Br J Anaesth; 2013 Jan; 110(1):122-7. PubMed ID: 23035052
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Next-generation Sequencing of RYR1 and CACNA1S in Malignant Hyperthermia and Exertional Heat Illness.
    Fiszer D; Shaw MA; Fisher NA; Carr IM; Gupta PK; Watkins EJ; Roiz de Sa D; Kim JH; Hopkins PM
    Anesthesiology; 2015 May; 122(5):1033-46. PubMed ID: 25658027
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recombination between the postulated CCD/MHE/MHS locus and RYR1 gene markers.
    Fagerlund TH; Islander G; Ranklev-Twetman E; Berg K
    Clin Genet; 1996 Dec; 50(6):455-8. PubMed ID: 9147872
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exclusion of malignant hyperthermia susceptibility (MHS) from a putative MHS2 locus on chromosome 17q and of the alpha 1, beta 1, and gamma subunits of the dihydropyridine receptor calcium channel as candidates for the molecular defect.
    Sudbrak R; Golla A; Hogan K; Powers P; Gregg R; Du Chesne I; Lehmann-Horn F; Deufel T
    Hum Mol Genet; 1993 Jul; 2(7):857-62. PubMed ID: 8395939
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Malignant hyperthermia deaths related to inadequate temperature monitoring, 2007-2012: a report from the North American malignant hyperthermia registry of the malignant hyperthermia association of the United States.
    Larach MG; Brandom BW; Allen GC; Gronert GA; Lehman EB
    Anesth Analg; 2014 Dec; 119(6):1359-66. PubMed ID: 25268394
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Malignant hyperthermia susceptibility in patients with exertional rhabdomyolysis: a retrospective cohort study and updated systematic review.
    Kraeva N; Sapa A; Dowling JJ; Riazi S
    Can J Anaesth; 2017 Jul; 64(7):736-743. PubMed ID: 28326467
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ryanodine receptor type 1 (RyR1) possessing malignant hyperthermia mutation R615C exhibits heightened sensitivity to dysregulation by non-coplanar 2,2',3,5',6-pentachlorobiphenyl (PCB 95).
    Ta TA; Pessah IN
    Neurotoxicology; 2007 Jul; 28(4):770-9. PubMed ID: 17023049
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia.
    Fujii J; Otsu K; Zorzato F; de Leon S; Khanna VK; Weiler JE; O'Brien PJ; MacLennan DH
    Science; 1991 Jul; 253(5018):448-51. PubMed ID: 1862346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.